Henry Schein appoints new head of US medical group


Henry Schein appoints new head of US medical group

Shironosov / iStock

Health care products and services provider Henry Schein has appointed Brad Connett as the president of its US medical group.

Connett was previously president of the company's commercial group for US medical.

In his new and expanded role, Connett will lead the medical group's strategic direction, management, and business performance. He will also be responsible for the group's sales, marketing, operations, business development, and technology solutions. He will report to David McKinley, senior vice president and chief commercial officer.

Connett joined Henry Schein in 1997 as vice president of the Southeast Region, following the company's acquisition of Roane-Barker, and was appointed vice president, Field Sales, in 2000. Connett has been a member of HIDA's Board of Directors since 2005, and served as chairman in 2011. He was instrumental in forming HIDA's Leadership Development Group, which brings together future health care industry leaders from both manufacturer and distributor companies to exchange ideas, network, and support industry initiatives.

"Brad has distinguished himself throughout his entire career, and he has been one of the architects of the remarkable growth that Henry Schein Medical has enjoyed in recent years," said Stanley Bergman, chairman of the board and chief executive officer of Henry Schein. "Brad's new appointment reflects his excellence as a senior leader and his ability to drive continued growth."

McKinley added: "Throughout the years, Henry Schein Medical has partnered with health care organizations to drive the development and execution of non-acute supply chain strategies. Brad's strategic vision, deep-rooted industry knowledge, and wide network will advance our ability to deliver innovative solutions that helps our medical professionals operate efficient and profitable practices."

Henry Schein, Appointment, US medical group, Brad Connett, US